Search research articles
Contact Us
Filters
Showing results (61-70 of 81) with videos related to
Page
of 9
Sort By:
Journal of Clinical Microbiology
|
May 15, 1999
Activity of gatifloxacin against Haemophilus influenzae and Moraxella catarrhalis, including susceptibility test development, E-test comparisons, and quality control guidelines for H. influenzae
R N Jones, D J Biedenbach, M E Erwin, et al.
Diagnostic Microbiology and Infectious Disease
|
February 6, 1999
The prevalence of fluoroquinolone resistance among clinically significant respiratory tract isolates of Streptococcus pneumoniae in the United States and Canada--1997 results from the SENTRY Antimicrobial Surveillance Program
G V Doern, M A Pfaller, M E Erwin, et al.
Diagnostic Microbiology and Infectious Disease
|
May 8, 1998
Antimicrobial activity and spectrum investigation of eight broad-spectrum beta-lactam drugs: a 1997 surveillance trial in 102 medical centers in the United States. Cefepime Study Group
R N Jones, M A Pfaller, G V Doern, et al.
Diagnostic Microbiology and Infectious Disease
|
July 1, 1992
Ofloxacin, a new broad-spectrum fluoroquinolone. Results from a Multicenter, National Comparative Activity Surveillance Study. The Ofloxacin Surveillance Group
R N Jones, L B Reller, L A Rosati, et al.
The Journal of Antimicrobial Chemotherapy
|
May 29, 2000
Anti-gonococcal activity of gemifloxacin against fluoroquinolone-resistant strains and a comparison of agar dilution and Etest methods
R N Jones, L M Deshpande, M E Erwin, et al.
Diagnostic Microbiology and Infectious Disease
|
April 23, 1999
Gatifloxacin (AM-1155, CG 5501) susceptibility testing interpretive criteria and quality control guidelines for dilution and disk (5-microgram) diffusion methods. The Quality Control Study Group
R N Jones, K C Kugler, M E Erwin, et al.
Diagnostic Microbiology and Infectious Disease
|
February 1, 1992
Interpretive criteria and quality control guidelines for lomefloxacin and meropenem in susceptibility tests of Haemophilus influenzae using Haemophilus test medium
M A Pfaller, R N Jones, J A Washington, et al.
Diagnostic Microbiology and Infectious Disease
|
September 1, 1992
Cefmetazole and trospectomycin in vitro susceptibility testing interpretive criteria and quality control guidelines for Neisseria gonorrheae
R N Jones, M E Erwin, J A Washington, et al.
Diagnostic Microbiology and Infectious Disease
|
June 4, 1999
Comparative antimicrobial activity of gatifloxacin tested against Streptococcus spp. including quality control guidelines and etest method validation. Quality Control Study Group
R N Jones, D M Johnson, M E Erwin, et al.
Diagnostic Microbiology and Infectious Disease
|
March 1, 1993
Multilaboratory evaluation of the in vitro activity of 13 beta-lactam antibiotics against 1474 clinical isolates of aerobic and anaerobic bacteria
P R Murray, R N Jones, S D Allen, et al.
Page
of 9
Search research articles
Search
Showing results (61-70 of 81) with videos related to
Sort By:
Page
of 9
Journal of Clinical Microbiology
|
May 15, 1999
Activity of gatifloxacin against Haemophilus influenzae and Moraxella catarrhalis, including susceptibility test development, E-test comparisons, and quality control guidelines for H. influenzae
R N Jones, D J Biedenbach, M E Erwin, et al.
Diagnostic Microbiology and Infectious Disease
|
February 6, 1999
The prevalence of fluoroquinolone resistance among clinically significant respiratory tract isolates of Streptococcus pneumoniae in the United States and Canada--1997 results from the SENTRY Antimicrobial Surveillance Program
G V Doern, M A Pfaller, M E Erwin, et al.
Diagnostic Microbiology and Infectious Disease
|
May 8, 1998
Antimicrobial activity and spectrum investigation of eight broad-spectrum beta-lactam drugs: a 1997 surveillance trial in 102 medical centers in the United States. Cefepime Study Group
R N Jones, M A Pfaller, G V Doern, et al.
Diagnostic Microbiology and Infectious Disease
|
July 1, 1992
Ofloxacin, a new broad-spectrum fluoroquinolone. Results from a Multicenter, National Comparative Activity Surveillance Study. The Ofloxacin Surveillance Group
R N Jones, L B Reller, L A Rosati, et al.
The Journal of Antimicrobial Chemotherapy
|
May 29, 2000
Anti-gonococcal activity of gemifloxacin against fluoroquinolone-resistant strains and a comparison of agar dilution and Etest methods
R N Jones, L M Deshpande, M E Erwin, et al.
Diagnostic Microbiology and Infectious Disease
|
April 23, 1999
Gatifloxacin (AM-1155, CG 5501) susceptibility testing interpretive criteria and quality control guidelines for dilution and disk (5-microgram) diffusion methods. The Quality Control Study Group
R N Jones, K C Kugler, M E Erwin, et al.
Diagnostic Microbiology and Infectious Disease
|
February 1, 1992
Interpretive criteria and quality control guidelines for lomefloxacin and meropenem in susceptibility tests of Haemophilus influenzae using Haemophilus test medium
M A Pfaller, R N Jones, J A Washington, et al.
Diagnostic Microbiology and Infectious Disease
|
September 1, 1992
Cefmetazole and trospectomycin in vitro susceptibility testing interpretive criteria and quality control guidelines for Neisseria gonorrheae
R N Jones, M E Erwin, J A Washington, et al.
Diagnostic Microbiology and Infectious Disease
|
June 4, 1999
Comparative antimicrobial activity of gatifloxacin tested against Streptococcus spp. including quality control guidelines and etest method validation. Quality Control Study Group
R N Jones, D M Johnson, M E Erwin, et al.
Diagnostic Microbiology and Infectious Disease
|
March 1, 1993
Multilaboratory evaluation of the in vitro activity of 13 beta-lactam antibiotics against 1474 clinical isolates of aerobic and anaerobic bacteria
P R Murray, R N Jones, S D Allen, et al.
Page
of 9